Beam Therapeutics Inc. - 10-Q Filing

Beam Therapeutics reports Q3 2025 financial results including updates on contingent consideration liabilities and financing agreements.

SEC EDGAR ·

Tickers: $BEAM

Read the full article at SEC EDGAR

More Regulatory news